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A conundrum has long lingered over association of cytosol elongation factor Tu (EF-Tu) with bacterial surface. Here we
investigated it with Acinetobacter baumannii, an emerging opportunistic pathogen associated with a wide spectrum of infectious
diseases. The gene for A. baumannii EF-Tu was sequenced, and recombinant EF-Tu was puriﬁed for antibody development. EF-Tu
onthebacterialsurfaceandtheoutermembranevesicles(OMVs)wasrevealedbyimmuneelectronmicroscopy,anditspresencein
theoutermembrane(OM)andtheOMVsubproteomeswasveriﬁedbyWesternblottingwiththeEF-Tuantibodiesandconﬁrmed
by proteomic analyses. EF-Tu in the OM and the OMV subproteomes bound to ﬁbronectin as detected by Western blot and
conﬁrmed by a label-free real-time optical sensor. The sensor that originates from photonic crystal structure in a total-Internal-
reﬂection (PC-TIR) conﬁguration was functionalized with ﬁbronectin for characterizing EF-Tu binding. Altogether, with a novel
combination of immunological, proteomical, and biophysical assays, these results suggest association of A. baumannii EF-Tu with
the bacterial cell surface, OMVs, and ﬁbronectin.
1.Introduction
A Gram-negative and obligate aerobic bacterial species, Aci-
netobacterbaumannii,hasemergedasoneofthemostimpor-
tant nosocomial pathogens [1–4], raising risks not only
regional but also global in the aftermath of war and natural
disasters. A. baumannii was identiﬁed in the US military
personnel deployed to Iraq and Afghanistan [5]. Interest-
ingly, more than 60% of the isolates were related to three
pan-European clones that, in fact, had been disseminated
in geographically distinct areas [6]. Besides, Acinetobacter
infections are associated with natural disasters, such as the
1999 earthquake in Turkey [7] and the 2008 earthquake in
China [8].
For such austerity of A. baumannii infections, little is
known about the pathogenesis. To explore the fundamental
mechanisms, we tested whether extracellular proteins of A.
baumannii mediate the bacterial attachment [9]. Proteins
were extracted from whole-cell lysate, outer membrane
(OM) fractions, and cell-free spent cultures (CFCs) of
the wild-type and the bioﬁlm mutants of A. baumannii
we isolated [9]. With a proteomic approach, translation
elongation factor (EF-Tu) of A. baumannii was detected in
cell-free cultures, the data suggesting release of EF-Tu from2 The Scientiﬁc World Journal
the bacterial cells. The release appeared unlikely to result
from cell death and lysis but rather likely to be regulated,
because the mutants, as viable as the wild type, exhibited
deﬁciency in the release and cell adhesion [9]. The EF-Tu
release seemed to be a puzzle to us as the primary function of
EF-Tu,whileremainingtobecharacterizedforA.baumannii,
is translation elongation as deduced from the E. coli EF-
Tu, because EF-Tu and translation are highly conserved
throughout the bacterial domain [10–12]. Speciﬁcally, in
the ﬁrst step of peptide chain elongation on ribosomes, EF-
Tu·GTP serves as a carrier of codon-speciﬁed aminoacyl-
tRNA to the ribosomal aminoacyl site. Eubacterial EF-Tus
belong to the superfamily of GTP-binding proteins. It is not
a membrane protein, since EF-Tu lacks a signal sequence and
transmembrane domains that mediate protein translocation
across cell membrane.
This has led to a conundrum concerning EF-Tu release.
The original clue to this question may come from a
study with the sucrose-dependent spectinomycin-resistant
mutants of Escherichia coli grown in the absence of sucrose
[13]. EF-Tu was detected in the OM fractions; its presence in
OM did not result from artiﬁcial binding during membrane
preparation. It was also found in the periplasm of Neisseria
gonorrhoeae [14]. Two decades after the initial ﬁnding, E.
coli EF-Tu was detected again in the OM fractions of the
cells adherent to abiotic surface [15]. The bacterial surface
association of EF-Tu has been further evidenced by EF-Tu
involvement in Staphylococcus aureus bioﬁlm development
[16],inmediatingattachmenttohumancellsbyLactobacillus
johnsonii [17]o rP. aeruginosa [18]. The EF-Tu surface asso-
ciation has been attested by its acting as a part of pathogen-
associated molecular patterns recognized by receptors on
eukaryote hosts [19], as a target for a serine-threonine
phosphatase involved in virulence and survival of Listeria
monocytogenes in the infected host [20], and as an active
protein eliciting innate [21] and acquired immunity [16, 22].
How the surface-associated EF-Tu is released still seems
to be an enigma. Our hypothesis was that A. baumannii
EF-Tu is associated with outer membrane vesicles (OMVs).
The rationale is based on the proteomic analyses that
have implicated EF-Tu association with OMVs in multiple
bacterial species [23] and with OM in A. baumannii [24],
and A. baumannii actually produces OMVs [25]. To test
it, we cloned and sequenced the EF-Tu encoding gene,
puriﬁed the recombinant EF-Tu (rEF-Tu), and produced EF-
Tu antibodies. Then we employed a combination of trans-
mission electron microcopy (TEM), proteomics, Western
blot, and an optical sensor to show that EF-Tu is associated
with OMVs and OM and binds to the host extracellular
matrix protein ﬁbronectin.
2. Results
2.1. A. baumannii EF-Tu. The EF-Tu encoding gene of A.
baumanniiATCC19606strainwassequencedandtheprotein
was puriﬁed for antibody development. The ATCC 19606
strain was chosen for novelty because its genome was not
completely sequenced and the EF-Tu encoding gene was
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Figure 1: Puriﬁcation of A. baumannii EF-Tu. Puriﬁcation of
A. baumannii rEF-Tu. (a) Overexpressed (lane 1) and column-
puriﬁed rEF-Tu (lane 2). (b) Immunoblot of column-puriﬁed rEF-
Tu with anti-His-tag monoclonal antibody. (c) Immunoblot of A.
baumannii cell lysate with rabbit prebleed (lane 1) and anti-rEF-Tu
antibodies (2). Immunoblot of rEF-Tu with the anti-rEF-Tu (3).
not studied at the time we started our investigation. The
availability of genome sequencing data for the ATCC 17978
strain greatly facilitated our study. Based on the genome
data, there are two genes for EF-Tu, namely tufAa and tufBa,
both identical [26], with reference to tufAe and tufBe of E.
coli. The tufAe deletion caused E. coli growth defect in rich
media,whilethetufBedeletiondidnot[27],theobservations
suggesting that tufAe is functional. These data led us to
clone and sequence tufAa of the A. baumannii 19606 strain.
Comparison of the tufAa sequences from 17978 and 19606
strains showed 99.8% identity; the small diﬀerence resulted
from two nucleotide changes located in 1,032 and 1,137
(Figure S1 in Supplementary Material available online at
doi: 10.1100/2012/128705)—GCA of the 19606 strain but
GCG of the 17978 strain—a silent mutation in the codon
for alanine. The gene of the 19606 strain was cloned and
His-tagged; rEF-Tu (48kDa) was expressed and puriﬁed
to homogeneity (Figure 1(a) lane 2). Immunoblots of the
His-tagged rEF-Tu showed that the tagged rEF-Tu reacted
with anti-His monoclonal antibodies (b), verifying that the
puriﬁed protein was His-tagged. The identity of rEF-Tu
was conﬁrmed with proteomic analysis as we described
before [9]. Furthermore, the antiserum speciﬁc to rEF-Tu
was produced. Immunoblots with the sera indicate that
the antiserum recognized both 43 kDa EF-Tu in cell lysate
(Figure 1(c) lane 2) and 48 kDa rEF-Tu in the puriﬁed
fraction (lane 3), but the preimmune serum did not (lane
1). The band of EF-Tu from the whole-cell extract appeared
wider (lane 2) than that from the puriﬁed fraction (lane 3),
suggesting that EF-Tu undergoes slight degradation in the
cell extract, in line with the previous data about cleavage of
E. coli EF-Tu by a phage-exclusion system [28].
2.2. EF-Tu Associated with OMVs and Cell Surface of A.
baumannii. Immune TEM of A. baumannii OMVs and the
cells was conducted with the antibodies speciﬁc for rEF-TuThe Scientiﬁc World Journal 3
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Figure 2: . EF-Tu visualized on A. baumannii OMVs and cells by immune TEM with EF-Tu antibodies. Immunogold TEM with anti-EF-Tu
antibodies showing localization of (a) EF-Tu on the isolated OMV and (c) on cell surface of A. baumannii. Immunogold with preimmune
serum shows no localization on OMVs (b) and cells (d). n = 40 OMVs. Bar: 100nm.
in order to examine whether EF-Tu is physically associated
with A. baumannii OMVs and cell surface. OMVs or cells
were incubated with the anti-rEF-Tu antibodies or the pre-
immune serum as a control. After washes, the samples
were probed with the gold-labeled anti-IgG antibodies and
examined under TEM (Figure 2). When OMVs were probed
with the primary EF-Tu antibodies and the secondary gold-
labeled antibodies, high-density dots of gold particles were
often observed associated with OMVs (a). When the cells
were probed, the gold particles appeared to deposit on the
cell surface (c), the result consistent with a previous ﬁnding
with thin sectioning of bacterial cells [17]. In contrast, when
the pre-immune serum was used, the gold dots were mostly
washed oﬀ (b, d). The rEF-Tu antibodies appeared highly
speciﬁc not only for rEF-Tu (Figure 1(c) lane 3) but also for
EF-Tu in the cell lysate (Figure 1(c) lane 2), the OM, and
the OMV fractions (Figure 3). Evidently, deposition of the
gold-labeled antibodies speciﬁc for the EF-Tu antibodies on
OMVs and cells appeared reﬂective of EF-Tu on the surfaces
of OMVs and the cells. The results provide the physical
evidenceforassociationofEF-TuwithOMVsandcellsurface
of A. baumannii.
2.3. EF-Tu Detected in OM and OMV Fractions. The physical
association of EF-Tu with OMVs and cell surface prompted
us to verify the presence of EF-Tu in the OM and the
OMV subproteomes. We performed 1D and 2D gel-based
Western blotting analyses. First, we resolved the proteins of
the OM (lane 1) and the OMV fractions (lane 2) in SDS-
PAGE (Figure 3(A)(a)). After the proteins in the gel were
transferred onto a membrane and probed with the anti-rEF-
Tu antibodies (Figure 3(A)(b)), a protein band of 43kDa4 The Scientiﬁc World Journal
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Figure 3: EF-Tu detected in OMV and OM fractions. Panel (A): (a) SDS-PAGE of proteins from OM (lane 1) and OMV fractions (2). (b)
Western blot of proteins from OM (lane 1) and OMV fractions (2) reacted with the EF-Tu antibody diluted at 1:3000. Control blot with
pre-immune serum (lane 3). Panel (B): 2D-based Western blot. Proteins from OM (a and c) and OMV fractions (b and d) were resolved by
isoelectric focusing (1st D) and then separated on a second dimension SDS-PAGE (2nd D). Proteins from the gel were blotted onto PVDF
membranes and probed with the anti-EF-Tu antibodies (c and d). Arrows: EF-Tu. Blot with pre-immune serum not shown.
the same as the EF-Tu mass was detected in the OM (lanes
1) and the OMV fractions (lane 2) [10]. In contrast, when
the membrane was probed with the pre-immune serum,
this protein band was not detected (lane 3). Second, to
address the limitation of 1D resolution, we conducted the
2D gel electrophoresis and probed the proteins for EF-Tu
(Figure 3(B)). EF-Tu was still detected by the antibodies in
the OM (a, c) and the OMV fractions (b, d), but not by the
pre-immune serum control.
While the evidence of Western blot for presence of EF-
Tu in the OM and the OMV fractions appeared to be
convincing, there were some drawbacks of Western blotting
analyses, such as lack of scope due to limitation on utilizing
costly arrays of antibodies to target multiple proteins.
Proteomic analyses of the OMV and the OM subproteomes
werecarriedouttoaddressthem.Brieﬂy,totalproteinsinthe
laneofSDS-PAGEasshowninFigure 3(A)(a)weresubjected
to the in vitro trypsin proteolysis and capillary LC/MS/MS.
The degraded peptide masses were determined and searched
across the bacterial protein databases with the P<0.05-
based MOWSE scoring algorithm [29]. By this signiﬁcance
threshold and the cut-oﬀ score of 50, 144 proteins were
identiﬁedintheOMVandtheOMfractions(Table 1).EF-Tu
w a sd e t e c t e di nb o t hO M Va n dO Ms u b p r o t e o m e s( n o .
57 in Table S2). The consistent results of EF-Tu obtained
by the immunological and the proteomic analyses attested
the validity of both methodologies in detection of EF-Tu.
The proteomic analyses also detected OmpA (no. 51) in the
OM and the OMV fractions, the results consistent with the
former ﬁnding [25]. The consistent results of the immune
TEM with the Western blotting and proteomic analyses
demonstrate that EF-Tu is indeed associated with OMVs,
unlikelyduetoproteincontaminationduringproteinsample
preparation.
Table 1: Summary of OMV and OM subproteomes.
Subproteomes SP∗-TM∗∗
domains (n) TM (n)N o n e ( n)T o t a l ( n)
OMV 12% (6) 59% (29) 29% (14) 34% (49)
OM 46% (32) 29% (20) 25% (17) 48% (69)
Common 39% (10) 27% (7) 34% (9) 18% (26)
33% (48) 39% (56) 28% (40) 100% (144)
∗Signal peptide; ∗∗transmembrane domains. Common: proteins detected
in both OMV and OM fractions.
2.4. The OMV- or OM-Associated EF-Tu Binding to Fi-
bronectin. As A. baumannii EF-Tu was detected in OMVs
and on the bacterial cell surface (Figures 2 and 3)a n d
Mycoplasma pneumoniae EF-Tu was found to bind the host
extracellular matrix protein ﬁbronectin [30], it could be
hypothesized that the OMV- and the OM-associated EF-
Tus of A. baumannii bind to ﬁbronectin. This hypothesis
was tested with the Western-based binding assays. The
proteins extracted from the OM (lane 1 of Figure 4(a))
and the OMV fractions (lane 2) were fractioned together
with rEF-Tu (lane 3) by SDS-PAGE and transferred onto
PVDF membranes. The membrane strips (1, 2, and 3) were
incubated with ﬁbronectin and then blotted against the
ﬁbronectin antibodies. A band of 43kDa corresponding to
the EF-Tu mass was detected in the OM (lane 1) and OMV
fractions (lane 2). A 48kDa band known to be rEF-Tu (lane
3) was detected but not by the pre-immune serum (lane 4).
Identity of EF-Tu in each of the bands was conﬁrmed by
proteomic analysis as we described previously [9]. To deal
withthelimitedpowerof1Dresolution,weperformedthe2-
D gel electrophoresis of the proteins from OM (Figure 4(b))
and probed the proteins for ﬁbronectin binding as above.The Scientiﬁc World Journal 5
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Figure 4: Binding of EF-Tu to ﬁbronectin examined by Western-blot-based binding assays. (a) Proteins were resolved by SDS-PAGE and
blotted onto PVDF membranes. Proteins from OM (lane 1) and OMVs (2) and the puriﬁed rEF-Tu (3) were probed with FN and anti-FN.
rEF-Tu (4) and proteins from OM (not shown) probed with anti-FN alone. (b) Immunoblot of 2-DE of proteins from OM probed with FN
followed by anti-FN. Arrow indicates EF-Tu conﬁrmed by protein sequencing.
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(b) Binding of EF-Tu to FN
Figure 5: Interaction of EF-Tu and ﬁbronectin characterized by a PC-TIR sensor. Binding of an analyte to a reactant causes resonant
wavelength shift that was measured throughout the process as a function of time. (a) Coating the sensor with ﬁbronectin. (i) The sensor
surface was calibrated with PBS and (ii) coated with ﬁbronectin (FN at 200μg/mL in a 200 μLv o l u m eo fP B Sa t2 5 ◦C). Immobilization of
FN onto the sensor caused resonant wavelength shift. (iii) The subsequent washes. (b) Binding of EF-Tu to FN. (I) Detection baseline of
the FN functionalized sensor. (II) EF-Tu at 20μg/mL (blue curve) or 50μg/mL (red) and a negative control (a portion of proteoglycan 4) at
20μg/mL (black) were incubated with FN at 25◦C for the indicated times. (III) The sensor was washed.
One conspicuous spot was seen, having a size of 43kDa; the
protein identity was determined to be EF-Tu by proteomic
analysisasabove.Evidently,theﬁbronectin-EF-Tucomplexes
were recognized by the ﬁbronectin antibodies.
Binding of rEF-Tu to ﬁbronectin was further charac-
terized by a novel label-free optical sensor (Figure 5). The
sensor is based on a photonic-crystal structure in a total-
internal-reﬂection (PC-TIR) conﬁguration. The unique
working principle and high sensitivity of the PC-TIR sensor
have been demonstrated by Ye and his colleagues [31–
34]. The assays with the PC-TIR sensor encompass two
steps: sensor coating and protein binding, each including
three phases. For coating as indicated in Figure 5(a), (i) the
baseline was calibrated with PBS; (ii) the sensor was coated
withﬁbronectin(200μg/mL)andthecoatingwasdetectedby
measuringtheresonantwavelengthshift;(iii)thesubsequent
washes removed the unbound protein molecules, leading to
a minor reduction in the resonance shift, but the substantial6 The Scientiﬁc World Journal
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Figure 6: EF-Tu delivery model. (a) A cell with budding and released OMVs revealed by TEM. Bar: 250nm. (b) A model derived from the
OM and the OMV subproteomic data as well as the immune TEM observations, depicting an OMV budding upwards (see Discussion for
details). OM: outer membrane; CW: cell wall; IM: inner membrane; PP: periplasm. Proteins in three subproteomes (common, OMV unique
and OM unique) are indicated therein.
changes still remained indicating the eﬀective coating of the
sensor by ﬁbronectin. The binding thickness of ﬁbronectin
on the sensor was determined to be 4.8nm corresponding
to the 4.2nm resonance shift calculated with a transfer
matrix method [31]. For protein binding as demonstrated
in Figure 5(b) (blue), after (I) the coating baseline was
calibrated, (II) EF-Tu was added onto the ﬁbronectin-coated
sensor surface. A gradual increase in resonance shift was
observed, demonstrating EF-Tu binding to ﬁbronectin. (III)
The unbound or weakly bound protein molecules were
washed oﬀ subsequently. The resonance shift level remained
high after wash, indicating strong binding of EF-Tu to
ﬁbronectin. When the EF-Tu concentration increased from
20 to 50μg/mL, the resonant shift level changed from
0.8nm to 1.1nm (blue and red in Figure 5(b)). The binding
thicknesses of EF-Tu are 0.91nm and 1.26nm, respectively.
The reason that the binding thickness did not increase as
much as the increase of the protein concentrations may be
attributed to binding saturations. In a sharp contrast, after
additionoftheproteoglycan4control,resonantshiftwasnot
observed; the resonant wavelength returned to the baseline
after wash (Black).
3. Discussion
A combination of biological, immunological, biophysical,
and proteomic methods was employed to test the hypothesis
stating that EF-Tu is associated with OMVs and binds to
ﬁbronectin. The results revealed by immune TEM show that
EF-Tu was physically associated with the OMVs and the cell
surface. Its presence in the OMV and the OM subproteomes
was veriﬁed by Western blotting and proteomic analyses.
EF-Tu carried by OMVs and OM was found to bind to
ﬁbronectin as detected with the Western blot- and the PC-
TIR-based sensor assays.
3.1.OMV-OMSubproteomesandPossibleMechanismsforEF-
Tu Delivery into OMVs. Our subproteomic analyses provide
clues to the mechanisms of EF-Tu delivery into OMVs. We
categorized the proteins in the OMV and the OM subpro-
teomes (Table 1). The ﬁrst consisted of the proteins detected
only in the OMV subproteome (Table S1). The second was
the common category of the proteins shared by the two
subproteomes (Table S2). The third comprised the proteins
present only in the OM subproteome (Table S3). While the
biological meaning of these subproteomes remains to be
deciphered, the current ﬁnding implies that there may be the
OMV-budding zones from which OMVs bud from OM. The
budding might be random as indicated in Figure 6(a).I fs o ,
OMVs produced via random budding should have displayed
irregular protein distributions; yet this presumption does
not appear reconciled with the subproteomic observations.
Rather, our data let us suggest the OMV budding zones
for protein delivery into OMVs (Figure 6(b)). First, the
proteins of the OMV subproteome seem to be located in the
OMV budding zones from which OMVs bud out and carry
these proteins with OMVs (Table S1). Second, the common
proteins seem likely to scatter over the two zones (Table
S2). Third, the proteins of the OM subproteome seem to be
distributed in the OMV-free zones and so not to be seen in
OMVs (Table S3). Based on the premise, EF-Tu that belongs
to the OM-OMV common subproteomes seems to scatter
over the OMV-budding and the OMV-free zones; it seems
to be delivered into OMVs through OMV budding from OM
(Figure 6(b)).Thismodelcanbeusedtoexplainthepresence
of EF-Tu in the OM, the OMVs, and the CFC fractions.
Understandable is the absence of the OM-only proteins (e.g.,
#78, 43 kDa glucose-sensitive porin; #91, 46 kDa urocanase;
#96, putative aromatic compound porin; #109, 43 kDa l-
sorbosone dehydrogenase in Table S3) from the OMVs
(Table S2) and the CFC fractions. In Bacillus subtilis, EF-
Tu localizes underneath the cell membrane, colocalizing andThe Scientiﬁc World Journal 7
interactingwithMreB,anactin-likecytoskeletalelementthat
playsaroleincellshapemaintenance[35].Thesepredictions
may stimulate future studies for their veriﬁcation.
3.2. EF-Tu and Other Cytosolic Proteins in OMV and OM
Subproteomes. One of the intriguing observations is the
presence of cytosolic proteins in the OMV and the OM
subproteomes, for example, DNA binding proteins (#18, 26,
45) in OMV and EF-Tu (#57) in the common subproteome.
Considering OM’s hydrophobic nature, we were tempted
to suspect cytosolic protein contamination. Nevertheless,
detection of DNA-binding proteins in OMVs seems unlikely
to be attributed to contamination, as DNA-binding proteins
and DNA were detected with in N. gonorrhoeae OMVs
[36, 37]. Since DNA was detected in A. baumannii OMVs
(Figure S2), it seems possible that the proteins are hitched
by DNA into OMVs or vice versa. Moreover, the presence
of EF-Tu in both OMV and OM subproteomes is not just
coincident but consistently documented [23] .I t sp r e s e n c ei n
OM did not result from artiﬁcial binding during membrane
preparation [13]. EF-Tu was detected in both subproteomes
of multiple species [23]. EF-Tu was found in OM fractions
of A. baumannii [24]. It also was present in OMVs of N.
meningitides [38, 39]a n dE. coli [40]. However, a former
proteomic analysis did not detect EF-Tu in the A. baumannii
OMV fraction [25]. This discrepancy with ours may be due
to diﬀerent strains and growth conditions used in their and
our studies. Kwon et al. used A. baumannii from clinical
isolates, but we employed the standard ATCC19606 strain.
Theygrewthecultureundershakingconditionwhileweused
plates. While a combination of physical, immunological, and
biochemical evidence appears to be convincing, we plan to
compare data acquired from the standard and the clinical
strains concerning the discrepancy.
3.3. Implications for Binding of A. baumannii EF-Tu to Fi-
bronectin: A. baumannii EF-Tu Bound to Fibronectin (Figures
4 and 5). The role of the binding seems to be intriguing. EF-
Tus of L. johnsonii [17]a n dP. aeruginosa [18]a r ei n v o l v e d
in bacterial attachment to human cells. Particularly, EF-Tu
is involved in bacterial infection of human monocyte-like
cells via binding to the cell-surface-associated nucleolin [41].
G i v e nt h a tﬁ b r o n e c t i nw a sf o u n dt ob i n dt om a c r o p h a g ea s
documented [42] and that A. baumannii EF-Tu was detected
in OMVs and on the bacterial cell surface, these data seem
to support a notion that A. baumannii EF-Tu contributes
to mediating adhesion of the bacterial cells and OMVs to
macrophages through binding to ﬁbronectin on the host
cells, a hypothesis to be tested in the future.
4.ExperimentalProcedures
4.1. Expression and Puriﬁcation of EF-Tu. The gene tufAa
encoding EF-Tu of A. baumannii was cloned by following the
manufacturer instruction (Novagen, San Diego, CA, USA).
Since the genome of the A. baumannii 19606 strain was
not available when we conducted this study, tufAa of A.
baumannii 17987 was used for designing speciﬁc primers
and PCR was performed with the 19606 DNA template.
Forwardprimer:5 -GACGACGACAAGATGATGGCTAAA-
GCCAAG-3  and the reverse primer: 5 -GAGGAGAAG-
CCCGGTCCGTCACTATATTATGCTTATGC-3 . The PCR
product (1,191bp) was cloned into the pTriEX-4 Ek/LIC
expression vector (Novagen, San Diego, CA, USA), which
added an N-terminal hexa-histidine (6xHis) for puriﬁcation
by aﬃnity chromatography and S-tag. The positive recom-
binant EF-Tu (rEF-Tu) clone DNA was veriﬁed by DNA
sequencinganalysis.TheexpressedrEF-TuwasfusedwithN-
terminus His-S-tags containing 48 amino acids and puriﬁed
bynickelaﬃnitychromatographyundernativeconditionsby
following the manufacturer protocol (Qiagen). The puriﬁed
protein was analyzed with SDS-PAGE to determine the pres-
enceofrEF-Tuandwasconﬁrmedfurtherbyimmunoblotby
using monoclonal antibody to His-tag. The identity of rEF-
Tu was further conﬁrmed by N-terminal microsequencing as
we described before [9].
4.2. Preparation of Antibody against rEF-Tu. The antiserum
speciﬁc to rEF-Tu was developed by ProSci Incorporated.
Brieﬂy, rabbits were injected subcutaneously with 100–
200μg rEF-Tu with complete Freund’s adjuvant. Individual
rabbits were boosted 3 times with the same amount of anti-
gen in incomplete Freund’s adjuvant at intervals of 21 days.
Serum samples were collected and used in immunological
studies. ProSci Incorporated provided us with sera prior to
immunization and 3 bleed collected serums.
4.3. Isolation of OMV and OMPs. A. baumannii
(ATCC19606) OMVs were isolated from LB agar plates as
described previously [43] with modiﬁcations. Colonies
g r o w no nL Ba g a rp l a t e sw e r es c r a p e do ﬀ and suspended in
PBS with gentle agitation to OD600nm of 5. Then, bacteria
were collected by low-speed centrifugation (6,000g) for
5min, and the recovered supernatant was centrifuged at
12,000g for 10min and further passed through the 0.2-μm
pore size ﬁlters (Millipore). OMVs in the supernatant were
then collected by ultra centrifugation at 100,000g for 12
hours at 4◦Ca n dr e s u s p e n d e di nP B S .O M P sw e r ee x t r a c t e d
according to Caldwell et al. [44].
4.4. TEM and Immunogold TEM. TEM was conducted
according to a standard protocol [25, 45]. For immuno-
gold TEM, A. baumannii cells and puriﬁed OMVs were
immunogold-labeled with the anti-EF-Tu antibodies as
described previously with some modiﬁcations [30]. Brieﬂy,
the cells and OMVs were incubated with 100mM Tris-HCl
buﬀer (pH 7.5) containing 1% bovine serum albumin (BSA)
supplemented with 1% heat inactivated goat serum (buﬀer
A) to reduce nonspeciﬁc binding. They were incubated
with anti-EF-Tu diluted 1:100 in buﬀer A at 37◦Cf o r
2hrs, washed with buﬀer A, and incubated with goat anti-
rabbit immunoglobulin-G- (IgG-) gold complex (average
size particle, 10nm, 1:20 dilution) suspended in PBS
containing 1% BSA (buﬀer B). After sequential washing
with buﬀer B, PBS, and deionized water, bacterial cells and8 The Scientiﬁc World Journal
OMVs were mounted onto Holey carbon ﬁlm nickel grids by
ﬁxing with 1% glutaraldehyde-4% formaldehyde for 20min
at room temperature. Grids were stained with 7% uranyl
acetate followed by Reynolds lead citrate for TEM.
4.5. Western Blot. Proteins from OMV and OM frac-
tions were separated on 10% SDS-PAGE [46] and stained
by Coomassie blue. The proteins were transferred elec-
trophoretically onto nitrocellulose membranes [47]. The
membrane strips were incubated with the A. baumannii
anti-rEF-Tu antibodies at a dilution of 1:3000 in 1%
(w/v) blotto for 2hrs at 25◦C. The membrane strips then
were washed, incubated in alkaline phosphatase-conjugated
goat anti-rabbit antibodies (Santa Cruz Biotechnologies,
Santa Cruz, CA), at a dilution of 1:5000 in 1% (w/v)
blotto for 1hr at 25◦C, washed, and developed with 5-
bromo-4-chloro-3-indolyl phosphate/NitroblueTetrazolium
(BCIP/NBT, Sigma). For 2D gel electrophoresis, proteins
from OMV and OM fractions were solubilized for iso-
electric focusing (IEF) in 8M urea, 2% CHAPS, 2% IPG
buﬀer (Amersham Biosciences), 20mM DTT, and traces
of bromophenol blue. Sample was loaded on a 13cm
Immobiline DryStrip pH 3–10 (Amersham Biosciences) by
rehydration and left under oil overnight. IEF was conducted
under 17,000Vh by using the Multiphor II (Amersham Bio-
sciences) at 20◦C. The IEF strips were equilibrated in Equili-
bration solution (0.05M Tris-HCl, 0.4M urea, 30% glycerol,
1% SDS (w/v), and 0.02M DTT) for 10 minutes. SDS-
PAGE (10% w/v) was conducted as previously [46]. After
separationofthesupernatantproteinsbyelectrophoresis,the
proteins in the gels were transferred electrophoretically onto
nitrocellulose membranes [47] .M e m b r a n e sw e r eb l o c k e d
andincubatedwiththeanti-rEF-Tuatadilutionof1:5000in
1% blotto for 1hr, washed, and developed with Sigma FAST
BCIP/NBT solution.
4.6. OM-OMV Subproteomic Analyses. The analysis was
performed as described previously [45, 48]. Brieﬂy, OMPs
were isolated as above, and OMV proteins were extracted
by resuspending in 2% (w/v) SDS and 100mmoll−1 DTT
and incubating at 25◦C for 5min. The proteins (30μg) were
fractionated by SDS-PAGE (10%, w/v). After staining, the
proteins-containing lane in replicate was sliced into pieces
(1 × 1mm) for in vitro trypsin proteolysis. Capillary liquid
chromatography-tandem mass spectrometry (LC/MS/MS)
wasperformed,andthepeptidesderivedfromtheproteinsin
the gel slices were determined with a linear ion trap tandem
mass spectrometer in which the top 7 eluting ions were
fragmented by collision-induced dissociation. Proteins were
identiﬁed by following a standard protocol [49], in which
MS/MS spectra were searched against the NCBI nonre-
dundant protein database (version 20100306; 10551781
sequences and 3596151245 residues) with a probability-
based database searching algorithm (Mascot, Matrix Sci-
ence). A score of each peptide entry was calculated by the
molecular weight search (MOWSE) peptide-mass database
developed previously [29] and the scoring algorithm. The
signiﬁcance threshold was set for P ≤ 0.05 in a search for
random matches, and the proteins consistently detected in
the replicates were counted.
4.7. Binding of Released EF-Tu to Fibronectin. Nitrocellulose
membranes transferred with proteins from OMV and OM
fractions were blocked, washed, and incubated with pure
ﬁbronectin (Sigma, human plasma ﬁbronectin) at 10μg/mL
for 24hr at 4◦C. Then, the membranes were washed and
incubated with the rabbit antiﬁbronectin antibodies at
1:10,000 dilution in 1% blotto for 2hr at room temperature.
Subsequently, the membranes were washed and incubated
with the alkaline-phosphatase-conjugated goat anti-rabbit
antibodies at a dilution of 1:20,000 in 1% blotto for 1hr,
washed, and developed as above.
4.8. Functionalization of PC-TIR Sensor. The sensor origi-
nates from a prototype of a photonic crystal structure in
a total-internal-reﬂection (PC-TIR) conﬁguration [33]. The
design and fabrication of the PC-TIR sensor was reported
by Ye and his coworkers [31, 32, 34]. Brieﬂy, a photonic
crystal (PC) structure with ﬁve alternating layers of silica and
titania was fabricated on a transparent BK7 glass substrate
by electron beam physical vapor deposition. A thin ﬁlm
of poly(methyl methacrylate) (PMMA) (A6, MicroChem)
was spin-coated on the top of the structure at 500rpm for
10sec, followed by 4,200rpm for 45sec. The sensor chip
was baked at 60◦C for 30 minutes. Two sample wells were
fabricated with polydimethylsiloxane and placed in a tight
contact with the top surface of the sensor chip. One is
used as the reference channel and the other as the signal
channel. Both wells were ﬁlled with PBS, and the resonant
wavelengths of the two channels were recorded to establish
the detection baseline. Fibronectin was immobilized on the
chip surface [50] through physical absorption by directly
adding ﬁbronectin (200μL, 200μg/mL) on the sensor chip
followed by incubation at 25◦C for the indicated time as
in Figure 5. Shift in resonant wavelength was measured and
recorded. The sensor surface was washed with PBS twice
and reﬁlled with 200μL PBS for measuring the thickness of
bound protein. Finally, PBS was replaced with the analyte
solution of EF-Tu or the proteoglycan 4 control in PBS
(100nM, 200μL). For the preparation of the control, the
DNA (1.2 kb) encoding a portion of proteoglycan 4 was
cloned; the polypeptide (44kDa) was expressed and puriﬁed
from baboon temporomandibular joint cells; it was tested
negative in ﬁbronectin binding by the same antibody-based
assay as shown in Figure 5 (unpublished data by Jennifer
McDaniel Schulze et al.).
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